Evidence map›Paper›PMID 38883405›Full record

ArticleGMS hygiene and infection control2024

Prevalence of heteroresistant Helicobacter pylori and treatment follow-up in patients in Ilam, Iran.

Sanaz Hosseini, Nahid Mahdian, Leila Gheitani, Mina Mahmoudi, Mohammad Raftari, Ali Hematian, Parvin Bahmaninejad, Behzad Badakhsh, Sobhan Ghafourian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in GMS hygiene and infection control, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sanaz HosseiniDepartment of Gastroenterology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Nahid MahdianDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Leila GheitaniDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Mina MahmoudiDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Mohammad RaftariClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Ali HematianDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Parvin BahmaninejadDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Behzad BadakhshDepartment of Gastroenterology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Sobhan GhafourianDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Special antibiotics are prescribed against Methods: In this cross-sectional descriptive study, 100 patients with clinical symptoms and suspected of being infected with Results: Out of a total of 50 samples, 3 were heteroresistant to clarithromycin (6%). Levofloxacin was applied in cases of heteroresistant samples, and the effectiveness was determined after one month of follow-up of patients. Conclusion: Patients with heteroresistance showed sensitivity to levofloxacin. After one month of follow-up, it was found that the effectiveness of this antibiotic was good. Therefore, this antibiotic was introduced as a more effective drug in patients with heteroresistant

Indexed as

follow-upHelicobacter pyloriheteroresistancelevofloxacinrecurrent infectiontargeted antibiotic therapy

Identifiers

PMID38883405
PMCPMC11177109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.